Shares of Brenntag AG (OTCMKTS:BNTGY – Get Free Report) have earned a consensus rating of “Reduce” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and eight have issued a hold rating on the company. The average 1 year target price among brokers that have covered the stock in the last year is $12.80.
Several analysts have recently weighed in on BNTGY shares. UBS Group raised shares of Brenntag from a “sell” rating to a “neutral” rating in a report on Thursday, April 30th. Deutsche Bank Aktiengesellschaft cut shares of Brenntag from a “buy” rating to a “hold” rating in a report on Tuesday, June 16th. DZ Bank raised Brenntag from a “strong sell” rating to a “hold” rating in a report on Monday, July 27th. Jefferies Financial Group raised Brenntag from a “moderate sell” rating to a “hold” rating in a report on Wednesday, May 20th. Finally, Morgan Stanley reiterated an “underweight” rating on shares of Brenntag in a research report on Friday.
Read Our Latest Stock Report on BNTGY
Brenntag Price Performance
Brenntag (OTCMKTS:BNTGY – Get Free Report) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.04. The company had revenue of $4.96 billion for the quarter, compared to analysts’ expectations of $4.66 billion. Brenntag had a net margin of 2.41% and a return on equity of 8.34%. As a group, analysts expect that Brenntag will post 0.8 earnings per share for the current fiscal year.
About Brenntag
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
See Also
- Five stocks we like better than Brenntag
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
